Halozyme Therapeutics HALO Payments to Acquire Property, Plant, and Equipment
Payments to Acquire Property, Plant, and Equipment at other companies
Other financials
Where this comes from
Reported directly by Halozyme Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The official record: Halozyme Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Halozyme Therapeutics's payments to acquire property, plant, and equipment.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Halozyme Therapeutics's payments to acquire property, plant, and equipment?
- Halozyme Therapeutics (HALO) reported payments to acquire property, plant, and equipment of $3.74M in Q1 2026.
- How has Halozyme Therapeutics's payments to acquire property, plant, and equipment changed year-over-year?
- Halozyme Therapeutics's payments to acquire property, plant, and equipment increased by 293.8% year-over-year, from $950K to $3.74M.
- What is the long-term trend for Halozyme Therapeutics's payments to acquire property, plant, and equipment?
- Over 3 years (2021 to 2025), Halozyme Therapeutics's payments to acquire property, plant, and equipment has grown at a 68.5% compound annual growth rate (CAGR), from $1.46M to $6.97M.